Hostname: page-component-5c6d5d7d68-sv6ng Total loading time: 0 Render date: 2024-08-07T22:41:39.471Z Has data issue: false hasContentIssue false
  • English
  • Français

The “NICE Guideline” on the treatment of depression

Published online by Cambridge University Press:  18 May 2011

David Goldberg
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The National Institute of Clinical Excellence (NICE) in the UK is responsible for producing evidence based guidelines for the treatment of most common illnesses, both physical and psychological. NICE uses a hierarchy of evidence, ranging from data from meta-analyses of randomised controlled trials (RCT's) at the apex, to the opinions of acknowledged experts at the bottom. The task of preparing guideline for depression involved us in performing clean meta-analyses of around 8,000 published RCTs of the treatment of this disorder. Where drug treatments were concerned we used three indicators of efficacy, as well as considering toxicity, tolerability and cost. We also distinguished between studies carried out in primary care, and studies in patients treated by the mental health services. We found it helpful to arrange our report in terms of a “stepped care” model, addressing the indications for patients being referred on for more specialised, and expensive, treatments. In the full guideline we included our doubts that depression was a homogenous clinical entity, and our awareness of the limitations of relying on randomised controlled trials (RCT's) as the only source of evidence. This Editorial summarises the content of the guideline on the treatment of depression and discusses how it was received and also what it did not say.

Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 15 , Issue 1 , March 2006 , pp. 11 - 15
Copyright
Copyright © Cambridge University Press 2006

References

REFERENCES

Angst, J. (1993). Severity of depression and benzodiazepine co-medication in relationship to efficacy of antidepressants in acute trials. A meta-analysis of moclobemide trials. Human Psychopharmacology 8, 401–407.CrossRefGoogle Scholar
Angst, J. (1995). The efficacy of moclobemide (1977–1994). A meta-analysis. Farmakoterapia w Psychiatrii I Neurologii. I-MAO, RIMA w Leczeniu depresji 1, 31–48.Google Scholar
Ankarberg, P. (2005). Questionable conclusions on psychodynamic psychotherapy and on comparisons between psychotherapy and antidepressants. Rapid Responses to: Editorials: Middleton, Hugh, Shaw, Ian, Hull, Sally, and Feder, Gene, NICE guidelines for the management of depression. British Medical Journal 330, 267–268 (9 February).Google Scholar
Berardi, D., Menchetti, M., Cevenini, N., Scaini, S., Versari, M. & De Ronchi, D. (2005). Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. Psychotherapy and Psychosomatics 74(4), 225–230.CrossRefGoogle ScholarPubMed
Geddes, J., Carney, S., Davies, C., Furukawa, T., Kupfer, D., Frank, E. & Goodwin, G.M. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361(9358), 653–661.CrossRefGoogle ScholarPubMed
Goldberg, D.P., Priven, M. & Üstün, T.B. (1998). The effects of detection and treatment of major depression in primary care: a naturalistic study in 15 centres. British Journal of General Practice 48, 1840–1844.Google Scholar
Harrison-Read, P. (2005). Curvilinear relationship between severity of depression and response to antidepressants. Rapid responses to: Education and Debate: Joanna Moncrieff and Irving Kirsch, Efficacy of antidepressants in adults. British Medical Journal 331, 155–157 (22 July).Google Scholar
Hatcher, S. (2005). Why stop at antidepressants? British Medical Journal 331, 158 (16 July).CrossRefGoogle ScholarPubMed
Khan, A., Leventhal, R.M., Khan, S. & Brown, W.A. (2002). Severity of depression and response to antidepressants and placebo: an analysis of the Food and drug Administration Database. Journal of Clinical Psychopharmacology 22, 40–45.CrossRefGoogle ScholarPubMed
Kahn, A., Brodhead, AE., Kolts, RL. & Brown, WA. (2005). Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. Journal of Psychiatric Research 39(2), 145–150.CrossRefGoogle Scholar
Middleton, H., Shaw, I., Hull, S. & Feder, G. (2005). NICE guidelines for the management of depression. British Medical Journal 330, 267–268 (5 February).CrossRefGoogle ScholarPubMed
Moncrieff, J. & Kirsch, I. (2005). Efficacy of antidepressants in adults. British Medical Journal 331, 155–157 (16 July).CrossRefGoogle ScholarPubMed
Pandarakalam, J.P. (2005). Are the antidepressants really antidepressants? Rapid responses to: Education and Debate: Joanna Moncrieff and Irving Kirsch, Efficacy of antidepressants in adults. British Medical Journal 331, 155–157 (20 July).Google Scholar
Pilling, S., Goldberg, D.P., Ferrier, N., Tylee, A., Caton, C., Burbeck, R. & Kenda, T. (2005). Efficacy of antidepressants in adults: a partial account of a complex problem. Rapid responses to: Education and Debate: Joanna Moncrieff and Irving Kirsch, Efficacy of antidepressants in adults. British Medical Journal 331, 155–157 (22 July).Google Scholar
Taylor, S. (2005). The future of SSRIs Rapid responses to: Education and Debate: Joanna Moncrieff and Irving Kirsch, Efficacy of antidepressants in adults. British Medical Journal 331, 155–157 (30 July).Google Scholar
Whitty, P. & Gilbody, S. (2005). NICE, but will they help people with depression? British Journal of Psychiatry 186, 177–178.CrossRefGoogle ScholarPubMed
Wijkstra, J., Lijmer, J., Balk, F.J., Geddes, J.R. & Nolen, W.A.(2004). Pharmacological treatment for psychotic depression. Cochrane Database of Systematic Reviews, Issue 4.Google Scholar
Wohlfarth, T.D., van Zwieten, B.J., Jitschak, G., Storosum, J.G. & van den Brink, W. (2005). Efficacy of antidepressants in adults - methodological issues Rapid responses to: Education and Debate: Joanna Moncrieff and Irving Kirsch, Efficacy of antidepressants in adults. British Medical Journal 331, 155–157 (22 July).Google Scholar